UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enablers of Mental Illness Stigma: A Scoping Review of Individual Perceptions

Mental illness, 2024, Vol.2024, p.1-23

2024

Volltextzugriff (PDF)

Biopsychosocial Profile of COVID-19 Patients Cared for in Public and Private Health Facilities in Kandahar Province, Afghanistan

Mental illness, 2023, Vol.2023, p.1-8

2023

Volltextzugriff (PDF)

Stress and Coping Mechanism among Students Residing in Private School Hostels

Mental illness, 2023, Vol.2023, p.1-10

2023

Volltextzugriff (PDF)

Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports

PloS one, 2018-10, Vol.13 (10), p.e0204443

2018

Volltextzugriff (PDF)

COVID-19: The Hidden Impact on Mental Health and Drug Addiction

Frontiers in psychiatry, 2020-07, Vol.11, p.767-767

2020

Volltextzugriff (PDF)

What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs

Brain sciences, 2020-10, Vol.10 (10), p.1

2020

Volltextzugriff (PDF)

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports

Journal of psychopharmacology (Oxford), 2021-06, Vol.35 (6), p.681-692

2021

Volltextzugriff (PDF)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues

Pharmaceuticals (Basel, Switzerland), 2023-08, Vol.16 (8), p.1177

2023

Volltextzugriff (PDF)

Is There a Potential of Misuse for Venlafaxine and Bupropion?

Frontiers in pharmacology, 2018-03, Vol.9, p.239-239

2018

Volltextzugriff (PDF)

Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

Frontiers in pharmacology, 2019-02, Vol.10, p.46-46

2019

Volltextzugriff (PDF)

Editorial: Misuse and abuse of prescription drugs in custodial settings

Frontiers in psychiatry, 2023-11, Vol.14, p.1339542-1339542

2023

Volltextzugriff (PDF)

Alprazolam-related deaths in Scotland, 2004–2020

Journal of psychopharmacology (Oxford), 2022-09, Vol.36 (9), p.1020-1035

2022

Volltextzugriff (PDF)

'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports

Current neuropharmacology, 2020-01, Vol.18 (9), p.809-837

2020

Volltextzugriff (PDF)

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

Medicina (Kaunas, Lithuania), 2019-08, Vol.55 (9), p.525

2019

Volltextzugriff (PDF)

Editorial: Prescribing psychotropics: Misuse, abuse, dependence, withdrawal and addiction, Volume II

Frontiers in psychiatry, 2022-10, Vol.13, p.1053896-1053896

2022

Volltextzugriff (PDF)

The Benzydamine Experience: A Systematic Review of Benzydamine Abuse

Current neuropharmacology, 2021-10, Vol.19 (10), p.1728-1737

2021

Volltextzugriff (PDF)

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants

Frontiers in psychiatry, 2021-05, Vol.12, p.657397-657397

2021

Volltextzugriff (PDF)

Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice

Current pharmaceutical design, 2022-01, Vol.28 (27), p.2241-2259

2022

Volltextzugriff (PDF)

Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction

Frontiers in psychiatry, 2021-04, Vol.12, p.688434-688434

2021

Volltextzugriff (PDF)

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases

Pharmaceuticals (Basel, Switzerland), 2022-05, Vol.15 (5), p.565

2022

Volltextzugriff (PDF)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

Brain sciences, 2018-04, Vol.8 (4), p.73

2018

Volltextzugriff (PDF)

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)

Pharmaceuticals (Basel, Switzerland), 2022-05, Vol.15 (6), p.675

2022

Volltextzugriff (PDF)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

Pharmaceuticals (Basel, Switzerland), 2023-07, Vol.16 (7), p.994

2023

Volltextzugriff (PDF)

3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report

Pharmaceuticals (Basel, Switzerland), 2024-03, Vol.17 (4), p.452

2024

Volltextzugriff (PDF)

1 – 25 von 137

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(136)
Koreanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Enablers of Mental Illness Stigma: A Scoping Review of Individual Perceptions

Do Long‐Acting Injectable Antipsychotics Influence Serum Levels of Brain‐Derived Neurotrophic Factor in People With Schizophrenia and Schizoaffective Disorder?

Biopsychosocial Profile of COVID-19 Patients Cared for in Public and Private Health Facilities in Kandahar Province, Afghanistan

Stress and Coping Mechanism among Students Residing in Private School Hostels

Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports

COVID-19: The Hidden Impact on Mental Health and Drug Addiction

What about “Pharming”? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs

Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues

Is There a Potential of Misuse for Venlafaxine and Bupropion?

Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

Editorial: Misuse and abuse of prescription drugs in custodial settings

Alprazolam-related deaths in Scotland, 2004–2020

'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review

Editorial: Prescribing psychotropics: Misuse, abuse, dependence, withdrawal and addiction, Volume II

The Benzydamine Experience: A Systematic Review of Benzydamine Abuse

Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants

Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice

Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset

3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report

Suchergebnisse filtern